Logo image of APOP

Cellect Biotechnology Ltd ADR (APOP) Stock Price, Quote, News and Overview

NASDAQ:APOP - Nasdaq -

13.17  +0.05 (+0.38%)

APOP Quote, Performance and Key Statistics

Cellect Biotechnology Ltd ADR

NASDAQ:APOP (10/28/2021, 8:24:41 PM)

13.17

+0.05 (+0.38%)

Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A
Statistics
52 Week High35.52
52 Week Low6.64
Market Cap12.87M
Shares977.00K
Float98.25K
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPON/A N/A


APOP short term performance overview.The bars show the price performance of APOP in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 -10 20 -20 30

APOP long term performance overview.The bars show the price performance of APOP in the last 1, 2 and 3 years. 1 year 2 years 3 years 20 40 60 80

The current stock price of APOP is 13.17 null. In the past month the price decreased by -28.66%. In the past year, price increased by 81.91%.

Cellect Biotechnology Ltd ADR / APOP Daily stock chart

About APOP

Company Profile

Cellect Biotechnology Ltd. offers biomedical services. It provides stem cell transplantation, disease management, regenerative medicine, clinical research and other services. Cellect Biotechnology Ltd. is based in TEL AVIV, Israel.

Company Info

Cellect Biotechnology Ltd ADR

23 HATA`AS STREET

KFAR SABA L3 44425

CEO: Shai Yarkoni

Phone: 972-9974-1444

Cellect Biotechnology Ltd ADR / APOP FAQ

What is the stock price of Cellect Biotechnology Ltd ADR today?

The current stock price of APOP is 13.17 null. The price increased by 0.38% in the last trading session.


What is the ticker symbol for Cellect Biotechnology Ltd ADR stock?

The exchange symbol of Cellect Biotechnology Ltd ADR is APOP and it is listed on the Nasdaq exchange.


On which exchange is APOP stock listed?

APOP stock is listed on the Nasdaq exchange.


What is Cellect Biotechnology Ltd ADR worth?

Cellect Biotechnology Ltd ADR (APOP) has a market capitalization of 12.87M null. This makes APOP a Nano Cap stock.


What are the support and resistance levels for Cellect Biotechnology Ltd ADR (APOP) stock?

Cellect Biotechnology Ltd ADR (APOP) has a support level at 13. Check the full technical report for a detailed analysis of APOP support and resistance levels.


Is Cellect Biotechnology Ltd ADR (APOP) expected to grow?

The Revenue of Cellect Biotechnology Ltd ADR (APOP) is expected to grow by 5% in the next year. Check the estimates tab for more information on the APOP EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy Cellect Biotechnology Ltd ADR (APOP) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does Cellect Biotechnology Ltd ADR (APOP) stock pay dividends?

APOP does not pay a dividend.


What is the Price/Earnings (PE) ratio of Cellect Biotechnology Ltd ADR (APOP)?

Cellect Biotechnology Ltd ADR (APOP) does not have a PE ratio as the earnings reported over the last twelve months were negative (-6).


APOP Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to APOP. When comparing the yearly performance of all stocks, APOP is one of the better performing stocks in the market, outperforming 72.18% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

APOP Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to APOP. APOP has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

APOP Financial Highlights

Over the last trailing twelve months APOP reported a non-GAAP Earnings per Share(EPS) of -6. The EPS increased by 34.78% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -155.68%
ROE N/A
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%37.23%
Sales Q2Q%N/A
EPS 1Y (TTM)34.78%
Revenue 1Y (TTM)N/A

APOP Ownership and Analysts


Ownership
Inst Owners4.84%
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
Analysts
Analysts0
Price TargetN/A
EPS Next YN/A
Revenue Next Year5%